Stamos Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Stamos Capital Partners's AMGN Position: Q2 2026 in Review
Stamos Capital Partners increased its Amgen (AMGN) stake by 9.7% in Q2 2026, buying an estimated $64.4K and bringing the position to 2,118 shares worth $767K. The position accounts for 0.12% of the portfolio, ranked #124.
Stamos Capital Partners first reported a position in AMGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.7M in Q3 2023. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Stamos Capital Partners held 2,118 shares of Amgen worth $767K as of Q2 2026.
- Stamos Capital Partners bought 188 Amgen shares in Q2 2026, an estimated $64.4K.
- Amgen made up 0.12% of Stamos Capital Partners's portfolio in Q2 2026, its #124 holding.
- Stamos Capital Partners first reported a position in Amgen in Q3 2022 and has held it in 16 quarters since.
- Stamos Capital Partners's Amgen position peaked at $3.7M in Q3 2023.
- 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Stamos Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.